About DACL
DACL is a publicly listed company based in Vadodara (India) founded in 1976. Ethyleneamines-based chemicals are manufactured by DACL in Vadodara, India. The company has 56 employees. Its Indian entity Diamines And Chemicals Limited reported revenue of ₹42.42 Cr. DACL offers products and services including Piperazine Anhydrous, Piperazine 68% Solution, Triethylenediamine, Ethylenediamine, and Diethylenetriamine. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.
Company details
DACL was established in 1976 and is based in Vadodara, India. Operations center on the production of chemicals derived from ethyleneamines within the chemical manufacturing sector. Facilities in Vadodara handle synthesis and processing of these compounds. The companys online presence is maintained through dacl.co.in, supporting inquiries and transactions. Focus remains on industrial applications of ethyleneamine derivatives across domestic and export markets.
- Headquarters Vadodara, India
- Employees 56
- Stage Public
- SectorsChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website dacl.co.in
- Social LinkedIn
- Legal Name Diamines & Chemicals Ltd.
- Market Cap₹235 Cr
DIAMINESQ · NSE
- Share Price₹233.93
+1.66% today
- Revenue₹38.48 Cr
FY 2025-26 · -46.2% YoY
- EBITDA−₹13.80 Cr
Margin -35.9%
- Net Profit−₹12.64 Cr
FY 2025-26 · -556.3% YoY
- ROE-7.9%
ROCE -8.3%
- Debt / Equity0.03
Interest cover -1.8x
- Employee Count56
Associated legal entities of DACL
DACL is associated with 2 registered companies on The Company Check; the primary company is Diamines And Chemicals Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Diamines And Chemicals Limited Listed CIN L24110GJ1976PLC002905 | Active | 12 May 1976 | Vadodara, Gujarat | ₹42.4 Cr | 164 | 8 | View details |
| Dacl Fine Chem Limited CIN U24304GJ2020PLC115143 | Active | 30 Jul 2020 | Vadodara, Gujarat | ₹0.1 Cr | 6 | View details |
Products & Services of DACL
DACL offers a comprehensive portfolio of products and services, including Piperazine Anhydrous, Piperazine 68% Solution, Triethylenediamine, Ethylenediamine, and Diethylenetriamine.
Used in pharmaceuticals and gas sweetening processes.
Applied in pharmaceutical and industrial applications.
Serves as a catalyst in polymer and resin production.
Utilized in agrochemicals and textile manufacturing.
Employed in coatings and industrial synthesis processes.
Board of directors of Diamines And Chemicals Limited (DACL)
Diamines And Chemicals Limited is the primary company behind DACL. The boards of the 2 registered companies of DACL currently have 8 directors; the longest-serving is Rajendra Surendra Chhabra, appointed in 2001. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajendra Surendra Chhabra DIN 00093384 | Director | 14 Mar 2001 | 25 yrs 7 mo | Diamines And Chemicals Limited |
| Kejal Vipinchandra Pandya DIN 07048046 | Director | 27 Apr 2018 | 8 yrs 6 mo | Diamines And Chemicals Limited |
| Dhruv Lalit Mehta DIN 02083226 | Director | 03 Dec 2019 | 6 yrs 11 mo | Diamines And Chemicals Limited |
| Tanmay Godiawala Naimish DIN 07084668 | Managing Director | 30 Jul 2020 | 6 yrs 3 mo | Dacl Fine Chem Limited, Diamines And Chemicals Limited |
| Mohak Amit Mehta DIN 00195898 | Director | 30 Jul 2020 | 6 yrs 3 mo | Dacl Fine Chem Limited |
| Amit Mahendra Mehta DIN 00073907 | Director | 30 Jul 2020 | 6 yrs 3 mo | Dacl Fine Chem Limited, Diamines And Chemicals Limited |
| Govindarajapuram Venkatachalam Seshadri DIN 02205898 | Director | 25 Aug 2020 | 6 yrs 2 mo | Dacl Fine Chem Limited |
| Priyam Shantilal Jhaveri DIN 00045038 | Director | 09 Aug 2024 | 2 yrs 3 mo | Diamines And Chemicals Limited |
IPO & Listings of DACL
DACL is a publicly listed company on the NSE with ticker symbol DIAMINESQ in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date25 Sep 2023
- Listed onNSE: DIAMINESQ
- Listed entityDiamines & Chemicals Ltd.
- Exchange sectorProcess industries
- ISININE591D01014
- Share price₹250.02 (+2.54% on the day) · 2026-10-14
- Market capitalisation₹247 Cr
- EPS (diluted, trailing year)₹-10.22
- Dividend yield0.41%
- Volume (last session)3,684
Financials of DACL
Exchange-reported figures of Diamines And Chemicals Limited, the listed company behind DACL (NSE: DIAMINESQ).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 38.48 | 71.47 | 104 | 111 | 66.11 | 62.82 | 35.58 |
| Revenue growth | -46.2% | -31.3% | -5.9% | +67.2% | +5.2% | - | - |
| EBITDA | (13.80) | 5.44 | 22.69 | 55.53 | 22.03 | 25.11 | 4.47 |
| EBITDA margin | -35.9% | +7.6% | +21.8% | +50.2% | +33.3% | +40.0% | +12.6% |
| Profit before tax | (13.95) | 4.79 | 22.20 | 56.36 | 22.09 | 25.79 | 0.09 |
| Net profit | (12.64) | 2.77 | 15.42 | 41.98 | 16.73 | 21.35 | 0.26 |
| Net profit margin | -32.9% | +3.9% | +14.8% | +38.0% | +25.3% | +34.0% | +0.7% |
| EPS (₹) | (12.72) | 2.79 | 15.81 | 42.83 | 17.08 | 21.46 | 0.25 |
| Balance sheet | |||||||
| Total assets | 166 | 162 | 148 | 135 | 101 | 85.65 | 48.62 |
| Net worth | 157 | 161 | 148 | 135 | 100 | 84.98 | 32.78 |
| Total debt | 8.19 | 0.03 | 0.00 | 0.00 | 0.00 | 0.30 | 15.56 |
| Cash & bank | 32.75 | 41.40 | 37.90 | 26.99 | 40.48 | 32.61 | 0.59 |
| Net working capital | 66.67 | 77.53 | 64.78 | 56.12 | 47.65 | 50.58 | 15.10 |
| Cash flow | |||||||
| Cash from operations | (10.85) | (5.02) | 21.90 | 16.28 | 27.27 | 15.37 | 7.12 |
| Cash from investing | (28.93) | 14.65 | (18.83) | (8.66) | (21.49) | (14.93) | 0.08 |
| Cash from financing | 18.03 | 9.75 | (3.13) | (6.01) | (5.28) | (3.69) | (7.29) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.87 | 14.37 | 9.29 | 7.64 | 9.30 | 12.25 | 17.93 | 17.51 |
| Revenue growth (YoY) | +6.1% | +17.3% | -48.2% | -56.4% | -51.5% | -27.3% | - | - |
| Other income | 0.59 | 0.51 | 0.92 | 0.53 | 0.61 | 1.89 | 0.93 | 0.77 |
| EBITDA | (1.75) | 0.38 | (3.11) | (2.85) | (3.89) | (3.95) | 1.68 | 1.51 |
| EBITDA margin | -17.7% | +2.6% | -33.5% | -37.3% | -41.8% | -32.2% | +9.4% | +8.6% |
| Depreciation | 0.96 | 0.92 | 0.96 | 0.98 | 0.96 | 0.89 | 0.87 | 0.88 |
| Interest | 0.01 | 0.02 | 0.10 | 0.13 | 0.07 | 0.01 | 0.09 | 0.17 |
| Profit before tax | (2.13) | (0.05) | (3.25) | (3.43) | (4.31) | (2.96) | 1.65 | 1.23 |
| Tax | 0.00 | 0.00 | (0.84) | (0.11) | (0.24) | (0.22) | 0.34 | 0.43 |
| Net profit | (2.13) | (0.05) | (2.41) | (3.32) | (4.07) | (2.74) | 1.31 | 0.80 |
| EPS (₹) | (2.19) | (0.10) | (2.40) | (3.47) | (4.24) | (2.87) | 1.29 | 0.77 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 38.46 | 71.39 | 104 | 111 | 66.11 | 62.82 | 69.30 |
| Revenue growth | -46.1% | -31.4% | -5.9% | +67.2% | +5.2% | -9.4% | - |
| EBITDA | (13.38) | 6.07 | 24.21 | 55.76 | 22.05 | 25.15 | 35.23 |
| EBITDA margin | -34.8% | +8.5% | +23.3% | +50.4% | +33.4% | +40.0% | +50.8% |
| Profit before tax | (12.53) | 6.31 | 24.09 | 56.66 | 22.11 | 25.83 | 35.18 |
| Net profit | (11.83) | 4.51 | 17.73 | 42.28 | 16.75 | 21.02 | 23.94 |
| Net profit margin | -30.8% | +6.3% | +17.0% | +38.2% | +25.3% | +33.5% | +34.6% |
| EPS (₹) | (11.05) | 4.59 | 18.16 | 43.16 | 17.09 | 21.50 | 24.52 |
| Balance sheet | |||||||
| Total assets | 172 | 166 | 151 | 135 | 101 | 85.69 | 66.07 |
| Net worth | 164 | 166 | 151 | 135 | 100 | 85.02 | 65.18 |
| Total debt | 8.19 | 0.03 | 0.00 | 0.00 | 0.00 | 0.30 | 0.00 |
| Cash & bank | 32.73 | 41.35 | 37.89 | 26.96 | 40.32 | 32.57 | 30.87 |
| Net working capital | 72.86 | 82.65 | 68.69 | 56.31 | 47.49 | 50.57 | 45.24 |
| Cash flow | |||||||
| Cash from operations | (11.77) | (5.75) | 19.73 | 16.31 | 27.31 | 15.37 | 25.95 |
| Cash from investing | (27.98) | 15.35 | (16.65) | (8.57) | (21.64) | (14.98) | (13.04) |
| Cash from financing | 18.03 | 9.75 | (3.13) | (6.01) | (5.28) | (3.69) | (9.17) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.84 | 14.37 | 9.29 | 7.64 | 9.30 | 12.23 | 17.90 | 17.51 |
| Revenue growth (YoY) | +5.8% | +17.5% | -48.1% | -56.4% | -51.4% | -27.3% | - | - |
| Other income | 0.84 | 0.68 | 1.08 | 0.72 | 0.78 | 2.05 | 1.09 | 0.92 |
| Total expenses | 11.50 | 13.91 | 12.33 | 10.37 | 13.08 | 16.07 | 16.09 | 15.91 |
| EBITDA | (1.66) | 0.46 | (3.04) | (2.73) | (3.78) | (3.84) | 1.81 | 1.60 |
| EBITDA margin | -16.9% | +3.2% | -32.7% | -35.7% | -40.6% | -31.4% | +10.1% | +9.1% |
| Depreciation | 0.88 | 0.84 | 0.88 | 0.89 | 0.88 | 0.80 | 0.79 | 0.80 |
| Interest | 0.01 | 0.02 | 0.10 | 0.13 | 0.07 | 0.01 | 0.15 | 0.15 |
| Profit before tax | (1.71) | 0.28 | (2.94) | (3.03) | (3.95) | (2.60) | 1.96 | 1.57 |
| Tax | 0.00 | 0.00 | (0.84) | (0.11) | (0.24) | (0.22) | 0.34 | 0.43 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.87 | 14.37 | 9.29 | 7.64 | 9.30 | 12.25 | 17.93 | 17.51 |
| Revenue growth (YoY) | +6.1% | +17.3% | -48.2% | -56.4% | -51.5% | -27.3% | - | - |
| Other income | 0.59 | 0.51 | 0.92 | 0.53 | 0.61 | 1.89 | 0.93 | 0.77 |
| EBITDA | (1.75) | 0.38 | (3.11) | (2.85) | (3.89) | (3.95) | 1.68 | 1.51 |
| EBITDA margin | -17.7% | +2.6% | -33.5% | -37.3% | -41.8% | -32.2% | +9.4% | +8.6% |
| Depreciation | 0.96 | 0.92 | 0.96 | 0.98 | 0.96 | 0.89 | 0.87 | 0.88 |
| Interest | 0.01 | 0.02 | 0.10 | 0.13 | 0.07 | 0.01 | 0.09 | 0.17 |
| Profit before tax | (2.13) | (0.05) | (3.25) | (3.43) | (4.31) | (2.96) | 1.65 | 1.23 |
| Tax | 0.00 | 0.00 | (0.84) | (0.11) | (0.24) | (0.22) | 0.34 | 0.43 |
| Net profit | (2.13) | (0.05) | (2.41) | (3.32) | (4.07) | (2.74) | 1.31 | 0.80 |
| EPS (₹) | (2.19) | (0.10) | (2.40) | (3.47) | (4.24) | (2.87) | 1.29 | 0.77 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Revenue | 38.48 | 71.47 | 104 | 111 | 66.11 | 62.82 | 35.58 |
| Revenue growth | -46.2% | -31.3% | -5.9% | +67.2% | +5.2% | - | - |
| Other income | 3.94 | 3.18 | 2.56 | 2.75 | 1.82 | 2.55 | 0.36 |
| Total expenses | 52.28 | 66.03 | 81.34 | 55.03 | 44.08 | 37.71 | 31.11 |
| Employee cost | 10.46 | 10.06 | 12.22 | 9.74 | 8.36 | 7.37 | 3.64 |
| EBITDA | (13.80) | 5.44 | 22.69 | 55.53 | 22.03 | 25.11 | 4.47 |
| EBITDA margin | -35.9% | +7.6% | +21.8% | +50.2% | +33.3% | +40.0% | +12.6% |
| Depreciation | 3.78 | 3.49 | 2.85 | 1.78 | 1.67 | 1.79 | 1.99 |
| Interest | 0.31 | 0.34 | 0.20 | 0.14 | 0.09 | 0.08 | 2.75 |
| Profit before tax | (13.95) | 4.79 | 22.20 | 56.36 | 22.09 | 25.79 | 0.09 |
| Tax | (1.41) | 1.82 | 6.30 | 14.45 | 5.38 | 4.81 | (0.17) |
| Net profit | (12.64) | 2.77 | 15.42 | 41.98 | 16.73 | 21.35 | 0.26 |
| Net profit margin | -32.9% | +3.9% | +14.8% | +38.0% | +25.3% | +34.0% | +0.7% |
| EPS (₹) | (12.72) | 2.79 | 15.81 | 42.83 | 17.08 | 21.46 | 0.25 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 10.05 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 |
| Reserves & surplus | 147 | 139 | 138 | 125 | 90.41 | 75.20 | 23.00 |
| Shareholders' funds (net worth) | 157 | 161 | 148 | 135 | 100 | 84.98 | 32.78 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 8.19 | 0.03 | 0.00 | 0.00 | 0.00 | 0.30 | 15.31 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 |
| Total debt | 8.19 | 0.03 | 0.00 | 0.00 | 0.00 | 0.30 | 15.56 |
| Total liabilities | 166 | 162 | 148 | 135 | 101 | 85.65 | 48.62 |
| Assets | |||||||
| Gross block | 89.63 | 85.64 | 84.00 | 55.33 | 51.13 | 38.09 | 65.32 |
| Net block | 65.14 | 63.79 | 65.39 | 40.06 | 37.55 | 22.46 | 27.33 |
| Capital work in progress | 19.41 | 2.26 | 0.83 | 21.39 | 1.88 | 0.15 | 1.20 |
| Investments | 10.20 | 16.07 | 15.76 | 13.30 | 12.67 | 5.94 | 0.08 |
| Inventories | 28.36 | 31.67 | 17.36 | 16.83 | 2.30 | 12.54 | 9.18 |
| Sundry debtors | 5.47 | 13.84 | 16.70 | 22.89 | 10.02 | 9.43 | 7.38 |
| Cash & bank balances | 32.75 | 41.40 | 37.90 | 26.99 | 40.48 | 32.61 | 0.59 |
| Loans & advances | 6.08 | 2.77 | 3.11 | 2.06 | 1.26 | 1.53 | 1.90 |
| Total current assets | 72.66 | 89.68 | 75.07 | 68.77 | 54.06 | 56.11 | 19.05 |
| Total current liabilities | 5.99 | 12.15 | 10.29 | 12.65 | 6.41 | 5.53 | 3.95 |
| Net working capital | 66.67 | 77.53 | 64.78 | 56.12 | 47.65 | 50.58 | 15.10 |
| Total assets | 166 | 162 | 148 | 135 | 101 | 85.65 | 48.62 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Opening cash | 21.92 | 2.54 | 2.61 | 1.00 | 0.50 | 3.75 | 0.26 |
| Net cash from operating activities | (10.85) | (5.02) | 21.90 | 16.28 | 27.27 | 15.37 | 7.12 |
| Net cash from investing activities | (28.93) | 14.65 | (18.83) | (8.66) | (21.49) | (14.93) | 0.08 |
| Net cash from financing activities | 18.03 | 9.75 | (3.13) | (6.01) | (5.28) | (3.69) | (7.29) |
| Net change in cash | (21.75) | 19.38 | (0.07) | 1.61 | 0.50 | (3.25) | (0.09) |
| Closing cash | 32.75 | 41.40 | 37.90 | 26.99 | 40.48 | 32.61 | 0.59 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2015-16 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -46.2% | -31.3% | -5.9% | +67.2% | +5.2% | - | - |
| EBITDA growth | -353.7% | -76.0% | -59.1% | +152.1% | -12.3% | - | - |
| PBT growth | - | -78.4% | -60.6% | +155.1% | -14.4% | - | +9998.0% |
| Net income growth | -556.3% | -82.0% | -63.3% | +150.9% | -21.6% | - | - |
| Revenue CAGR (3Y) | -29.7% | +2.6% | +18.3% | +45.9% | +19.1% | +12.7% | -14.7% |
| EBITDA CAGR (3Y) | - | -37.3% | -3.3% | +131.6% | +65.1% | +62.8% | -16.8% |
| Profitability & leverage | |||||||
| Net income margin | -32.6% | +4.2% | +15.3% | +37.9% | +25.3% | +33.4% | +0.7% |
| Return on capital employed | -8.3% | +3.3% | +15.8% | +48.0% | +23.8% | +30.2% | +5.9% |
| Return on net worth | -7.9% | +1.9% | +11.2% | +35.7% | +18.1% | +24.7% | +0.8% |
| Debt / equity | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.60 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 |
| Interest cover | -1.76 | 17.44 | 1.01 | 0.26 | 0.44 | 0.34 | 110.89 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.44 | 0.84 | 1.49 | 2.08 | 1.48 | 1.65 | 0.63 |
| Inventory turnover | 1.28 | 2.92 | 6.09 | 11.56 | 8.91 | 5.01 | 3.71 |
| Debtors turnover | 3.99 | 4.68 | 5.26 | 6.72 | 6.80 | 6.66 | 5.21 |
| EPS (₹) | (12.72) | 2.79 | 15.81 | 42.83 | 17.08 | 21.46 | 0.25 |
| Dividend per share (₹) | 0.00 | 1.00 | 2.50 | 3.00 | 3.00 | 5.00 | 0.00 |
| Book value per share (₹) | 156.41 | 151.90 | 151.36 | 137.43 | 102.41 | 86.87 | 30.64 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.84 | 14.37 | 9.29 | 7.64 | 9.30 | 12.23 | 17.90 | 17.51 |
| Revenue growth (YoY) | +5.8% | +17.5% | -48.1% | -56.4% | -51.4% | -27.3% | - | - |
| Other income | 0.84 | 0.68 | 1.08 | 0.72 | 0.78 | 2.05 | 1.09 | 0.92 |
| Total expenses | 11.50 | 13.91 | 12.33 | 10.37 | 13.08 | 16.07 | 16.09 | 15.91 |
| EBITDA | (1.66) | 0.46 | (3.04) | (2.73) | (3.78) | (3.84) | 1.81 | 1.60 |
| EBITDA margin | -16.9% | +3.2% | -32.7% | -35.7% | -40.6% | -31.4% | +10.1% | +9.1% |
| Depreciation | 0.88 | 0.84 | 0.88 | 0.89 | 0.88 | 0.80 | 0.79 | 0.80 |
| Interest | 0.01 | 0.02 | 0.10 | 0.13 | 0.07 | 0.01 | 0.15 | 0.15 |
| Profit before tax | (1.71) | 0.28 | (2.94) | (3.03) | (3.95) | (2.60) | 1.96 | 1.57 |
| Tax | 0.00 | 0.00 | (0.84) | (0.11) | (0.24) | (0.22) | 0.34 | 0.43 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 38.46 | 71.39 | 104 | 111 | 66.11 | 62.82 | 69.30 |
| Revenue growth | -46.1% | -31.4% | -5.9% | +67.2% | +5.2% | -9.4% | - |
| Other income | 4.62 | 3.75 | 2.73 | 2.75 | 1.82 | 2.55 | 2.09 |
| Total expenses | 51.84 | 65.32 | 79.83 | 54.80 | 44.06 | 37.67 | 34.07 |
| Employee cost | 10.35 | 9.76 | 11.64 | 9.73 | 8.36 | 7.37 | 5.38 |
| EBITDA | (13.38) | 6.07 | 24.21 | 55.76 | 22.05 | 25.15 | 35.23 |
| EBITDA margin | -34.8% | +8.5% | +23.3% | +50.4% | +33.4% | +40.0% | +50.8% |
| Depreciation | 3.46 | 3.17 | 2.66 | 1.71 | 1.67 | 1.79 | 2.06 |
| Interest | 0.31 | 0.34 | 0.19 | 0.14 | 0.09 | 0.08 | 0.08 |
| Profit before tax | (12.53) | 6.31 | 24.09 | 56.66 | 22.11 | 25.83 | 35.18 |
| Tax | (1.41) | 1.82 | 6.30 | 14.45 | 5.38 | 4.81 | 11.19 |
| Net profit | (11.83) | 4.51 | 17.73 | 42.28 | 16.75 | 21.02 | 23.94 |
| Net profit margin | -30.8% | +6.3% | +17.0% | +38.2% | +25.3% | +33.5% | +34.6% |
| EPS (₹) | (11.05) | 4.59 | 18.16 | 43.16 | 17.09 | 21.50 | 24.52 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 10.05 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 |
| Reserves & surplus | 153 | 143 | 141 | 125 | 90.46 | 75.24 | 55.40 |
| Shareholders' funds (net worth) | 164 | 166 | 151 | 135 | 100 | 85.02 | 65.18 |
| Secured loans | 8.19 | 0.03 | 0.00 | 0.00 | 0.00 | 0.30 | 0.00 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 8.19 | 0.03 | 0.00 | 0.00 | 0.00 | 0.30 | 0.00 |
| Total liabilities | 172 | 166 | 151 | 135 | 101 | 85.69 | 66.07 |
| Assets | |||||||
| Gross block | 74.20 | 70.21 | 68.58 | 41.93 | 51.13 | 38.09 | 32.92 |
| Net block | 50.78 | 49.11 | 50.39 | 26.89 | 37.55 | 22.47 | 20.42 |
| Capital work in progress | 19.41 | 2.26 | 0.83 | 21.39 | 1.88 | 0.15 | 1.16 |
| Investments | 24.52 | 30.16 | 29.63 | 26.76 | 12.87 | 5.99 | 2.07 |
| Inventories | 28.29 | 31.62 | 17.31 | 16.83 | 2.30 | 12.54 | 7.00 |
| Sundry debtors | 5.47 | 13.77 | 16.70 | 22.89 | 10.02 | 9.43 | 12.49 |
| Cash & bank balances | 32.73 | 41.35 | 37.89 | 26.96 | 40.32 | 32.57 | 30.87 |
| Loans & advances | 12.31 | 7.97 | 6.92 | 2.27 | 1.26 | 1.56 | 0.96 |
| Total current assets | 78.80 | 94.71 | 78.82 | 68.95 | 53.90 | 56.10 | 51.32 |
| Total current liabilities | 5.94 | 12.06 | 10.13 | 12.64 | 6.41 | 5.53 | 6.08 |
| Net working capital | 72.86 | 82.65 | 68.69 | 56.31 | 47.49 | 50.57 | 45.24 |
| Total assets | 172 | 166 | 151 | 135 | 101 | 85.69 | 66.07 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 21.88 | 2.53 | 2.58 | 0.85 | 0.46 | 3.75 | 0.00 |
| Net cash from operating activities | (11.77) | (5.75) | 19.73 | 16.31 | 27.31 | 15.37 | 25.95 |
| Net cash from investing activities | (27.98) | 15.35 | (16.65) | (8.57) | (21.64) | (14.98) | (13.04) |
| Net cash from financing activities | 18.03 | 9.75 | (3.13) | (6.01) | (5.28) | (3.69) | (9.17) |
| Net change in cash | (21.72) | 19.35 | (0.05) | 1.73 | 0.39 | (3.29) | 3.75 |
| Closing cash | 32.73 | 41.35 | 37.89 | 26.96 | 40.32 | 32.57 | 30.87 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -46.1% | -31.4% | -5.9% | +67.2% | +5.2% | -9.4% | - |
| EBITDA growth | -320.4% | -74.9% | -56.6% | +152.9% | -12.3% | -28.6% | - |
| PBT growth | - | -73.8% | -57.5% | +156.3% | -14.4% | -26.6% | +97.3% |
| Net income growth | -362.3% | -74.6% | -58.1% | +152.4% | -20.3% | -12.2% | - |
| Revenue CAGR (3Y) | -29.7% | +2.6% | +18.3% | +16.9% | +11.8% | +17.7% | +25.8% |
| EBITDA CAGR (3Y) | - | -35.0% | -1.3% | +16.5% | +5.2% | +35.7% | +55.7% |
| Profitability & leverage | |||||||
| Net income margin | -28.9% | +6.3% | +17.1% | +38.2% | +25.3% | +33.5% | +34.6% |
| Return on capital employed | -7.2% | +4.2% | +16.9% | +48.1% | +23.8% | +34.2% | +60.1% |
| Return on net worth | -6.8% | +2.8% | +12.4% | +35.9% | +18.1% | +28.0% | +42.1% |
| Debt / equity | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -1.84 | 11.72 | 0.88 | 0.26 | 0.44 | 0.34 | 0.24 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.53 | 1.03 | 1.88 | 2.38 | 1.48 | 1.77 | 2.19 |
| Inventory turnover | 1.28 | 2.92 | 6.09 | 11.56 | 8.91 | 6.43 | 8.49 |
| Debtors turnover | 4.00 | 4.69 | 5.26 | 6.72 | 6.80 | 5.73 | 6.88 |
| EPS (₹) | (11.05) | 4.59 | 18.16 | 43.16 | 17.09 | 21.50 | 24.52 |
| Dividend per share (₹) | 0.00 | 1.00 | 2.50 | 3.00 | 3.00 | 5.00 | 8.00 |
| Book value per share (₹) | 162.47 | 156.42 | 154.08 | 137.80 | 102.46 | 86.91 | 66.62 |
Web traffic of DACL
The website of DACL (dacl.co.in) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 14.5% vs previous month
Top companies in Core & Diversified Chemicals
3 companies that operate in the same segment as DACL (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate | 1979 | Pune, Maharashtra, India | USD 1.21 B | 1,020 | ||
Specialty chemicals are manufactured through integrated R&D and production processes. | 2023 | Bengaluru, Karnataka, India | USD 72.97 M | USD 23.86 M | ||
Manufactures coal tar and basic industrial chemicals. | 1987 | Kolkata, West Bengal, India | USD 24 M | USD 515.01 M | 1,161 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dacl
Complete news archive for DACL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DACL
DACL was founded in 1976.
DACL is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
DACL has 56 employees.
The primary company behind DACL, Diamines And Chemicals Limited, reported revenue of ₹42.42 Cr for FY 2026, down 46% year on year.
DACL was established in 1976 and is based in Vadodara, India. Operations center on the production of chemicals derived from ethyleneamines within the chemical manufacturing sector. Facilities in Vadodara handle synthesis and processing of these compounds. The companys online presence is maintained through dacl.co.in, supporting inquiries and transactions. Focus remains on industrial applications of ethyleneamine derivatives across domestic and export markets.
DACL offers Piperazine Anhydrous, Piperazine 68% Solution, Triethylenediamine, Ethylenediamine, and Diethylenetriamine.
Yes, DACL is publicly traded on NSE under the ticker symbol DIAMINESQ.
DACL is associated with 2 legal entities: Diamines And Chemicals Limited, Dacl Fine Chem Limited.
The legal entities of DACL currently have 10 directors, including Tanmay Godiawala Naimish, Mohak Amit Mehta, Hemaxi Vinayakrao Pawar and others.